(Q41560119)

3 October 2017

1 reference

title

Pharmacotherapy of alcohol dependence (English)

1 reference

3 October 2017

0 references

Zernig G

1

1 reference

3 October 2017

Fabisch K

series ordinal

2

1 reference

3 October 2017

Fabisch H

series ordinal

3

1 reference

3 October 2017

publication date

1 July 1997

1 reference

Trends in Pharmacological Sciences

3 October 2017

published in

1 reference

3 October 2017

volume

18

1 reference

3 October 2017

issue

7

1 reference

3 October 2017

page(s)

229-231

1 reference

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

“Never Believe an Alcoholic”? On the Validity of Self-Report Measures of Alcohol Dependence and Related Constructs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Psychiatric outcome in alcoholic liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Ascitic cirrhosis in relation to alcohol consumption

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Effect of naltrexone on alcohol "high" in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Experience of a "slip" among alcoholics treated with naltrexone or placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Tiapride in the prevention of relapse in recently detoxified alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Randomized controlled trial in alcohol relapse prevention: role of atenolol, alcohol craving, and treatment adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Bromocriptine in the prevention of alcohol abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Buspirone in the treatment of alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Disulfiram treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Improvements in the community-reinforcement approach to alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

Alcoholism treatment by disulfiram and community reinforcement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901075-4

7 January 2021

10.1016/S0165-6147(97)01075-4

Identifiers

DOI

1 reference

3 October 2017

1 reference